Cinacalcet Tablet
Product Images NDC 76282-676

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cinacalcet (NDC 76282-676). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (A22d813f E662 4337 82d9 4def3faad43c 01)

Chemical structure of cinacalcet hydrochloride, showing the molecular framework including a trifluoromethyl-substituted benzene ring, an amine group, and a fused bicyclic aromatic system, with the hydrochloride salt indicated.*

FDA Label Image

Image (A22d813f E662 4337 82d9 4def3faad43c 02)

A line graph comparing parathyroid hormone (PTH) levels (pg/mL) over 26 weeks between patients given placebo and those given cinacalcet tablets. PTH levels decrease over time with cinacalcet tablets, while remaining fairly stable with placebo, with error bars shown for each data point.*

FDA Label Image

Image (A22d813f E662 4337 82d9 4def3faad43c 03)

A line graph comparing calcium-phosphorus product levels (Ca x P mg/dL) over 26 weeks between Cinacalcet tablets and placebo. The x-axis represents weeks from 0 to 26, and the y-axis represents Ca x P levels. Cinacalcet tablets show a marked decrease in Ca x P levels over time compared to placebo, which remains relatively stable.*

FDA Label Image

Image (A22d813f E662 4337 82d9 4def3faad43c 04)

A line graph depicting calcium levels (mg/dL) over time (weeks) in patients with parathyroid carcinoma. The x-axis shows weeks from baseline through titration and maintenance phases; the y-axis indicates calcium concentration. Data points include error bars and annotations for titration and maintenance periods with patient numbers below the x-axis.*

FDA Label Image

Image (A22d813f E662 4337 82d9 4def3faad43c 05)

A line graph depicting serum calcium levels (mg/dL) over an 80-week period, including titration, end of treatment, and maintenance phases, with error bars shown for each data point. The x-axis represents weeks and the y-axis represents calcium concentration.*

FDA Label Image

Image (A22d813f E662 4337 82d9 4def3faad43c 06)

Label for Cinacalcet Hydrochloride Tablets 30 mg oral tablets. The label indicates each film-coated tablet contains 33 mg of cinacalcet hydrochloride equivalent to 30 mg of cinacalcet. It includes storage instructions and manufacturer details for Ascent Pharmaceuticals, Inc., and Exelan Pharmaceuticals, Inc. The package size is 30 tablets with labeling including NDC 76282-674-30 and the Exelan Pharmaceuticals logo.*

FDA Label Image

Image (A22d813f E662 4337 82d9 4def3faad43c 07)

Cinacalcet Hydrochloride Tablets 60 mg film-coated, oral tablets packaged in a bottle label showing 30 tablets. The label includes storage instructions, manufacturers Ascent Pharmaceuticals, Inc. and Exelan Pharmaceuticals, Inc., and a barcode. The product is for prescription use only, labeled with NDC 76282-675-30.*

FDA Label Image

Image (A22d813f E662 4337 82d9 4def3faad43c 08)

Cinacalcet Hydrochloride Tablets 90 mg film-coated tablets label by Exelan Pharmaceuticals Inc. The label states the NDC 76282-676-30, package size of 30 tablets, and Rx only. Storage instructions and manufacturer information are included alongside a barcode and QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.